Cue lays off 25%, prioritizing preclinical autoimmune assets over clinical-stage cancer drugs 0 26.07.2024 11:32 Fiercebiotech.com Cue lays off 25%, prioritizing preclinical autoimmune assets over clinical-stage cancer drugs jwaldron Fri, 07/26/2024 - 04:32
